跳轉至內容
Merck
  • Biomechanical properties of the thoracic aneurysmal wall: differences between bicuspid aortic valve and tricuspid aortic valve patients.

Biomechanical properties of the thoracic aneurysmal wall: differences between bicuspid aortic valve and tricuspid aortic valve patients.

The Annals of thoracic surgery (2014-06-03)
Caroline Forsell, Hanna M Björck, Per Eriksson, Anders Franco-Cereceda, T Christian Gasser
摘要

The prevalence for thoracic aortic aneurysms (TAAs) is significantly increased in patients with a bicuspid aortic valve (BAV) compared with patients who have a normal tricuspid aortic valve (TAV). TAA rupture is a life-threatening event, and biomechanics-based simulations of the aorta may help to disentangle the molecular mechanism behind its development and progression. The present study used polarized microscopy and macroscopic in vitro tensile testing to explore collagen organization and mechanical properties of TAA wall specimens from BAV and TAV patients. Circumferential sections of aneurysmal aortic tissue from BAV and TAV patients were obtained during elective operations. The distribution of collagen orientation was captured by a Bingham distribution, and finite element models were used to estimate constitutive model parameters from experimental load-displacement curves. Collagen orientation was almost identical in BAV and TAV patients, with a highest probability of alignment along the circumferential direction. The strength was almost two times higher in BAV samples (0.834 MPa) than in TAV samples (0.443 MPa; p<0.001). The collagen-related stiffness (Cf) was significantly increased in BAV compared with TAV patients (Cf=7.45 MPa vs 3.40 MPa; p=0.003), whereas the elastin-related stiffness was similar in both groups. A trend toward a decreased wall thickness was seen in BAV patients (p=0.058). The aneurysmal aortas of BAV patients show a higher macroscopic strength, mainly due to an increased collagen-related stiffness, compared with TAV patients. The increased wall stiffness in BAV patients may contribute to the higher prevalence for TAAs in this group.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
I型胶原蛋白 溶液 来源于大鼠尾, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, powder
Sigma-Aldrich
胶原蛋白 来源于大鼠尾, Bornstein and Traub Type I, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于小牛皮, Bornstein and Traub Type I, solid, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原 来源于牛跟腱, powder, suitable for substrate for collagenase
Sigma-Aldrich
胶原蛋白 来源于小牛皮, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白IV型 来源于人类细胞培养基, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于鸡胸软骨, Type II (Miller), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type I (Sigma Type VIII), powder
Sigma-Aldrich
胶原 来源于牛气管软骨, Bornstein and Traub Type II, powder
Sigma-Aldrich
胶原蛋白 来源于 Engelbreth-Holm-Swarm 小鼠肉瘤基底膜, Type IV (Miller), lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
胶原 人, Bornstein and Traub Type I, acid soluble, powder, ~95% (SDS-PAGE)
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type III (Sigma Type X), powder
Sigma-Aldrich
胶原蛋白 来源于牛鼻中隔, Bornstein and Traub Type II, powder
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type IV, solution, suitable for cell culture, High Performance
Sigma-Aldrich
胶原蛋白 来源于人类胎盘, Bornstein and Traub Type V (Sigma Type IX), powder
Sigma-Aldrich
胶原 来源于人类胎盘, Bornstein and Traub Type IV, powder
Sigma-Aldrich
胶原 来源于兔皮肤, Bornstein and Traub Type I, powder